Read the full stored bill text
Illinois General Assembly - Full Text of SB3383
Select Language
×
The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.
Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.
The English language version is always the official and authoritative version of this website.
NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.
Choose Language
English
Afrikaans
Albanian
Arabic
Armenian
Azerbaijani
Basque
Bengali
Bosnian
Catalan
Croatian
Czech
Danish
Dutch
Esperanto
Estonian
Filipino
Finnish
French
Galician
Georgian
German
Greek
Gujarati
Haitian Creole
Hausa
Hawaiian
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Interlingua
Interlingue
Inuktitut
Irish
Italian
Japanese
Javanese
Kannada
Khmer
Korean
Latin
Latvian
Lithuanian
Luxembourgish
Macedonian
Malagasy
Malayalam
Maltese
Maori
Marathi
Myanmar
Nepali
Norwegian
Odia
Pashto
Punjabi
Romanian
Russian
Samoan
Sango
Sanskrit
Sardinian
Sindhi
Sinhala
Slovak
Slovenian
Somali
Southern Sotho
Spanish
Sundanese
Swahili
Swedish
Tamil
Telugu
Thai
Tigrinya
Tonga
Turkish
Ukrainian
Urdu
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Powered by
Translate
Close
Illinois General Assembly
Top Navigation Bar
Translate
Learn
Select General Assembly
Search the 104th General Assembly
Enter search terms for legislation, members, committees, or schedules.
ILGA.GOV
LEGISLATION & LAWS
Bills & Resolutions
Public Acts
Illinois Compiled Statutes
Illinois Constitution
Search Legislation
Glossary
Guide
Reports & Inquiry
Legislative Reports
Special Reports
FTP Site
Legislator Lookup
Capitol Complex Phone Numbers
Rules & Regulations
Illinois Register
Administrative Rules
Senate
Members
Schedules
Committees
Request for Remote Testimony
Journals
Transcripts
Rules
Audio/Video
FOIA Information
Senate Employment Opportunities
Media Guidelines
House
Members
Schedules
Committees
Submit testimony for House Committees
Journals
Transcripts
Rules
Audio/Video
FOIA Information
House Employment Opportunities
Log In
Mobile Top Bar
Search the 104th General Assembly
Enter keywords to search the Illinois General Assembly website.
Full Text of SB3383
Home
Legislation
Full Text
SB3383 - 104th General Assembly
Bill Status
Full Text
Votes
Witness Slips
Select Menu
Bill Status
Full Text
Votes
Witness Slips
Printer Friendly Version
Introduced
Printer Friendly Version
Introduced
Open PDF
104TH GENERAL ASSEMBLY
State of Illinois
2025 and 2026
SB3383
Introduced 2/4/2026, by Sen. Laura Ellman
SYNOPSIS AS INTRODUCED:
210 ILCS 85/3
210 ILCS 85/6.23
210 ILCS 83/Act rep.
Amends the Hospital Licensing Act. Defines "pathogens of
epidemiological concern". Provides that each hospital shall develop and
implement comprehensive interventions to prevent and control pathogens of
epidemiological concern (instead of multidrug-resistant organisms) that
take into consideration guidelines of the U.S. Centers for Disease Control
and Prevention or recommendations from the Infectious Disease Society of
America, the Society for Healthcare Epidemiology of America, the
Association for Professionals in Infection Control and Epidemiology, or
the Pediatric Infectious Disease Society for the management of
multidrug-resistant organisms in health care settings. Within 12 months
after the effective date of the amendatory Act, requires each hospital to
adopt a policy for preventing and controlling the transmission of
pathogens of epidemiological concern. Establishes reporting requirements
for hospitals with patients carrying pathogens of epidemiological concern.
Repeals the MRSA Screening and Reporting Act.
LRB104 20090 BAB 33541 b
A BILL FOR
SB3383
LRB104 20090 BAB 33541 b
1
AN ACT concerning regulation.
2
Be it enacted by the People of the State of Illinois,
3
represented in the General Assembly:
4
Section 5.
The Hospital Licensing Act is amended by
5
changing Sections 3 and 6.23 as follows:
6
(210 ILCS 85/3)
7
Sec. 3.
As used in this Act:
8
(A) "Hospital" means any institution, place, building,
9
buildings on a campus, or agency, public or private, whether
10
organized for profit or not, devoted primarily to the
11
maintenance and operation of facilities for the diagnosis and
12
treatment or care of 2 or more unrelated persons admitted for
13
overnight stay or longer in order to obtain medical, including
14
obstetric, psychiatric and nursing, care of illness, disease,
15
injury, infirmity, or deformity.
16
The term "hospital", without regard to length of stay,
17
shall also include:
18
(a) any facility which is devoted primarily to
19
providing psychiatric and related services and programs
20
for the diagnosis and treatment or care of 2 or more
21
unrelated persons suffering from emotional or nervous
22
diseases;
23
(b) all places where pregnant females are received,
SB3383
- 2 -
LRB104 20090 BAB 33541 b
1
cared for, or treated during delivery irrespective of the
2
number of patients received; and
3
(c) on and after January 1, 2023, a rural emergency
4
hospital, as that term is defined under subsection
5
(kkk)(2) of Section 1861 of the federal Social Security
6
Act; to provide for the expeditious and timely
7
implementation of this amendatory Act of the 102nd General
8
Assembly, emergency rules to implement the changes made to
9
the definition of "hospital" by this amendatory Act of the
10
102nd General Assembly may be adopted by the Department
11
subject to the provisions of Section 5-45 of the Illinois
12
Administrative Procedure Act.
13
The term "hospital" includes general and specialized
14
hospitals, tuberculosis sanitaria, mental or psychiatric
15
hospitals and sanitaria, and includes maternity homes,
16
lying-in homes, and homes for unwed mothers in which care is
17
given during delivery.
18
The term "hospital" does not include:
19
(1) any person or institution required to be licensed
20
pursuant to the Nursing Home Care Act, the Specialized
21
Mental Health Rehabilitation Act of 2013, the ID/DD
22
Community Care Act, or the MC/DD Act;
23
(2) hospitalization or care facilities maintained by
24
the State or any department or agency thereof, where such
25
department or agency has authority under law to establish
26
and enforce standards for the hospitalization or care
SB3383
- 3 -
LRB104 20090 BAB 33541 b
1
facilities under its management and control;
2
(3) hospitalization or care facilities maintained by
3
the federal government or agencies thereof;
4
(4) hospitalization or care facilities maintained by
5
any university or college established under the laws of
6
this State and supported principally by public funds
7
raised by taxation;
8
(5) any person or facility required to be licensed
9
pursuant to the Substance Use Disorder Act;
10
(6) any facility operated solely by and for persons
11
who rely exclusively upon treatment by spiritual means
12
through prayer, in accordance with the creed or tenets of
13
any well-recognized church or religious denomination;
14
(7) an Alzheimer's disease management center
15
alternative health care model licensed under the
16
Alternative Health Care Delivery Act;
17
(8) any veterinary hospital or clinic operated by a
18
veterinarian or veterinarians licensed under the
19
Veterinary Medicine and Surgery Practice Act of 2004 or
20
maintained by a State-supported or publicly funded
21
university or college; or
22
(9) a psychiatric residential treatment facility
23
certified under the Psychiatric Residential Treatment
24
Facilities (PRTF) Act.
25
(B) "Person" means the State, and any political
26
subdivision or municipal corporation, individual, firm,
SB3383
- 4 -
LRB104 20090 BAB 33541 b
1
partnership, corporation, company, association, or joint stock
2
association, or the legal successor thereof.
3
(C) "Department" means the Department of Public Health of
4
the State of Illinois.
5
(D) "Director" means the Director of Public Health of the
6
State of Illinois.
7
(D-5) "Pathogens of epidemiological concern" means any
8
infectious agent that has one or more of the following
9
characteristics:
10
(1) a propensity for transmission within health care
11
facilities based on published reports from:
12
(A) the Centers for Disease Control and
13
Prevention; or
14
(B) the Department of Public Health;
15
(2) the occurrence of temporal or geographic clusters
16
of 2 or more patients;
17
(3) antimicrobial resistance implications;
18
(4) association with serious clinical disease or
19
increased morbidity and mortality;
20
(5) a newly discovered or reemerging pathogen; or
21
(6) any other characteristic determined by a state or
22
local health department.
23
(E) "Perinatal" means the period of time between the
24
conception of an infant and the end of the first month after
25
birth.
26
(F) "Federally designated organ procurement agency" means
SB3383
- 5 -
LRB104 20090 BAB 33541 b
1
the organ procurement agency designated by the Secretary of
2
the U.S. Department of Health and Human Services for the
3
service area in which a hospital is located; except that in the
4
case of a hospital located in a county adjacent to Wisconsin
5
which currently contracts with an organ procurement agency
6
located in Wisconsin that is not the organ procurement agency
7
designated by the U.S. Secretary of Health and Human Services
8
for the service area in which the hospital is located, if the
9
hospital applies for a waiver pursuant to 42 U.S.C.
10
1320b-8(a), it may designate an organ procurement agency
11
located in Wisconsin to be thereafter deemed its federally
12
designated organ procurement agency for the purposes of this
13
Act.
14
(G) "Tissue bank" means any facility or program operating
15
in Illinois that is certified by the American Association of
16
Tissue Banks or the Eye Bank Association of America and is
17
involved in procuring, furnishing, donating, or distributing
18
corneas, bones, or other human tissue for the purpose of
19
injecting, transfusing, or transplanting any of them into the
20
human body. "Tissue bank" does not include a licensed blood
21
bank. For the purposes of this Act, "tissue" does not include
22
organs.
23
(H) "Campus", as this term applies to operations, has the
24
same meaning as the term "campus" as set forth in federal
25
Medicare regulations, 42 CFR 413.65.
26
(Source: P.A. 104-147, eff. 8-1-25.)
SB3383
- 6 -
LRB104 20090 BAB 33541 b
1
(210 ILCS 85/6.23)
2
Sec. 6.23.
Prevention and control of
pathogens of
3
epidemiological concern
Multidrug-Resistant Organisms
.
4
(a)
Each hospital shall develop and implement
5
comprehensive interventions to prevent and control
pathogens
6
of epidemiological concern
multidrug-resistant organisms
7
(MDROs), including methicillin-resistant Staphylococcus
8
aureus (MRSA), vancomycin-resistant enterococci (VRE), and
9
certain gram-negative bacilli (GNB)
, that take into
10
consideration guidelines of the U.S. Centers for Disease
11
Control and Prevention
or recommendations from (A) the
12
Infectious Disease Society of America, (B) the Society for
13
Healthcare Epidemiology of America, (C) the Association for
14
Professionals in Infection Control and Epidemiology, and (D)
15
the Pediatric Infectious Disease Society
for the management of
16
multidrug-resistant organisms
MDROs
in
health care
healthcare
17
settings.
The Department may also consider any other credible
18
scientific bodies or organizations in adopting rules and
19
developing policies and findings in relation to the management
20
of multidrug-resistant organisms in health care settings.
The
21
Department shall adopt administrative rules that require
22
hospitals to perform an annual facility-wide infection control
23
risk assessment and enforce hand hygiene and contact
24
precaution requirements.
25
(b) Within 12 months after the effective date of this
SB3383
- 7 -
LRB104 20090 BAB 33541 b
1
amendatory Act of the 104th General Assembly, each hospital
2
shall adopt a policy for preventing and controlling the
3
transmission of pathogens of epidemiological concern that
4
shall, at a minimum, contain:
5
(1) a facility risk assessment to identify pathogens
6
of epidemiological concern that considers elements such as
7
the probability of occurrence, as determined through
8
surveillance, the potential impact of a pathogen, and
9
measures the hospital has implemented to mitigate the risk
10
to patients, health care workers, and visitors; and
11
(2) appropriate evidence-based procedures and
12
intervention strategies to identify patients carrying
13
pathogens of epidemiological concern and to help prevent
14
patients from transmitting pathogens of epidemiological
15
concern to other patients and health care workers.
16
(c) A hospital that has, through appropriate testing,
17
identified a patient who has a pathogen of epidemiological
18
concern shall report the patient to the United States
19
Department of Health and Human Services or the National
20
Healthcare Safety Network of the United States Centers for
21
Disease Control and Prevention, as required by the Department
22
of Public Health or the United States Centers for Medicare and
23
Medicaid services.
24
(Source: P.A. 95-282, eff. 8-20-07; 95-876, eff. 8-21-08.)
25
(210 ILCS 83/Act rep.)
SB3383
- 8 -
LRB104 20090 BAB 33541 b
1
Section 10.
The MRSA Screening and Reporting Act is
2
repealed.
Footer
Disclaimer
This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.
Contact ILGA Webmaster
ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies
ILGA.GOV
2026 ILGA.gov | All Rights Reserved |
ADA
|
Disclaimers
|
Learn
This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.
Contact ILGA Webmaster
ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies
ILGA.GOV
2026 ILGA.gov | All Rights Reserved |
ADA
|
Disclaimers
|
Learn